| Primary |
| Drug Use For Unknown Indication |
20.2% |
| Idiopathic Pulmonary Fibrosis |
14.9% |
| Product Used For Unknown Indication |
12.2% |
| Pharyngitis |
7.4% |
| Cataract |
4.3% |
| Back Pain |
3.7% |
| Cough |
3.7% |
| Allergy Prophylaxis |
3.2% |
| Pemphigus |
3.2% |
| Prophylaxis |
3.2% |
| Threatened Labour |
3.2% |
| Immunosuppression |
2.7% |
| Inflammation |
2.7% |
| Tendonitis |
2.7% |
| Blood Pressure Decreased |
2.1% |
| Deafness Neurosensory |
2.1% |
| Glioblastoma Multiforme |
2.1% |
| Insomnia |
2.1% |
| Metastases To Bone |
2.1% |
| Neonatal Respiratory Distress Syndrome Prophylaxis |
2.1% |
|
| Anaphylactic Shock |
13.0% |
| Insomnia |
7.4% |
| Vertigo |
7.4% |
| Maternal Drugs Affecting Foetus |
5.6% |
| Premature Baby |
5.6% |
| Pulmonary Oedema |
5.6% |
| Stevens-johnson Syndrome |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Anaphylactoid Shock |
3.7% |
| Foetal Growth Restriction |
3.7% |
| Hypokalaemia |
3.7% |
| Keratitis Herpetic |
3.7% |
| Melaena |
3.7% |
| Paralysis |
3.7% |
| Spinal Cord Compression |
3.7% |
| Swelling Face |
3.7% |
| Tendon Rupture |
3.7% |
| Tenosynovitis |
3.7% |
| Throat Tightness |
3.7% |
| Trichophytic Granuloma |
3.7% |
|
| Secondary |
| Cancer Pain |
46.4% |
| Product Used For Unknown Indication |
9.3% |
| Sinus Disorder |
6.6% |
| Drug Use For Unknown Indication |
4.1% |
| Lung Neoplasm Malignant |
4.0% |
| Gastric Ulcer |
3.6% |
| Rheumatoid Arthritis |
3.5% |
| Cerebral Atrophy |
3.0% |
| Metastases To Bone |
2.7% |
| Delirium |
2.3% |
| Self Injurious Behaviour |
2.2% |
| Pharyngeal Cancer Stage Unspecified |
2.0% |
| Prophylaxis |
1.5% |
| Anaesthesia |
1.3% |
| Asthma |
1.3% |
| Brain Neoplasm |
1.3% |
| Intentional Self-injury |
1.3% |
| Scleritis |
1.3% |
| Colitis Ulcerative |
1.2% |
| Neuralgia |
1.0% |
|
| Somnolence |
15.0% |
| Renal Impairment |
10.0% |
| Gamma-glutamyltransferase Increased |
6.7% |
| Hepatic Function Abnormal |
6.7% |
| Self Injurious Behaviour |
6.7% |
| Toxic Skin Eruption |
6.7% |
| Sudden Death |
5.0% |
| Acute Pulmonary Oedema |
3.3% |
| Chorioretinopathy |
3.3% |
| Deafness |
3.3% |
| Foetal Growth Restriction |
3.3% |
| Hypoalbuminaemia |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Leukocytosis |
3.3% |
| Oliguria |
3.3% |
| Pyrexia |
3.3% |
| Respiratory Failure |
3.3% |
| Spinal Compression Fracture |
3.3% |
| Steroid Therapy |
3.3% |
| Vision Blurred |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.1% |
| Drug Use For Unknown Indication |
10.7% |
| Prophylaxis |
9.2% |
| Rheumatoid Arthritis |
7.5% |
| Hepatitis C |
5.3% |
| Behcet's Syndrome |
5.1% |
| Hiv Infection |
4.3% |
| Colitis Ulcerative |
3.6% |
| Insomnia |
2.6% |
| Uveitis |
2.5% |
| Ovarian Cancer Recurrent |
2.4% |
| Constipation |
2.3% |
| Glaucoma |
2.3% |
| Cytomegalovirus Chorioretinitis |
2.2% |
| Infection Prophylaxis |
2.2% |
| Psoriasis |
2.0% |
| Graft Versus Host Disease |
1.9% |
| Adverse Event |
1.7% |
| Headache |
1.7% |
| Osteoporosis |
1.6% |
|
| White Blood Cell Count Decreased |
13.3% |
| Pneumonia |
8.9% |
| Speech Disorder |
8.9% |
| Anaphylactic Reaction |
6.7% |
| Platelet Count Decreased |
6.7% |
| Glaucoma |
4.4% |
| Leukaemia |
4.4% |
| Lung Neoplasm Malignant |
4.4% |
| Paraesthesia |
4.4% |
| Rash |
4.4% |
| Asthma |
3.3% |
| Cataract |
3.3% |
| Duodenal Ulcer Perforation |
3.3% |
| Infectious Peritonitis |
3.3% |
| Keratopathy |
3.3% |
| Myocardial Infarction |
3.3% |
| Prostate Cancer |
3.3% |
| Sepsis |
3.3% |
| Thrombocytopenia |
3.3% |
| Urticaria |
3.3% |
|
